Arch Biopartners Inc
XTSX:ARCH

Watchlist Manager
Arch Biopartners Inc Logo
Arch Biopartners Inc
XTSX:ARCH
Watchlist
Price: 2 CAD -0.5% Market Closed
Market Cap: 129.3m CAD
Have any thoughts about
Arch Biopartners Inc?
Write Note

Arch Biopartners Inc
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Arch Biopartners Inc
Total Equity Peer Comparison

Comparables:
ABCL
RP
IOT

Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
Arch Biopartners Inc
XTSX:ARCH
Total Equity
-CA$6.6m
CAGR 3-Years
-11%
CAGR 5-Years
-24%
CAGR 10-Years
-37%
Abcellera Biologics Inc
NASDAQ:ABCL
Total Equity
$1.2B
CAGR 3-Years
12%
CAGR 5-Years
151%
CAGR 10-Years
N/A
Replicel Life Sciences Inc
XTSX:RP
Total Equity
-CA$6.6m
CAGR 3-Years
-12%
CAGR 5-Years
-29%
CAGR 10-Years
N/A
Innovotech Inc
XTSX:IOT
Total Equity
CA$729.1k
CAGR 3-Years
-9%
CAGR 5-Years
57%
CAGR 10-Years
N/A

See Also

What is Arch Biopartners Inc's Total Equity?
Total Equity
-6.6m CAD

Based on the financial report for Jun 30, 2024, Arch Biopartners Inc's Total Equity amounts to -6.6m CAD.

What is Arch Biopartners Inc's Total Equity growth rate?
Total Equity CAGR 10Y
-37%

Over the last year, the Total Equity growth was -14%. The average annual Total Equity growth rates for Arch Biopartners Inc have been -11% over the past three years , -24% over the past five years , and -37% over the past ten years .

Back to Top